Transplantation in rare lymphoproliferative and histiocytic disorders.

about

Transplantation in rare lymphoproliferative and histiocytic disorders.

Item

http://www.wikidata.org/entity/Q38259618

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Transplantation in rare lymphoproliferative and histiocytic disorders.

@en

type

Item

label

Transplantation in rare lymphoproliferative and histiocytic disorders.

@en

prefLabel

Transplantation in rare lymphoproliferative and histiocytic disorders.

@en

P1476

Transplantation in rare lymphoproliferative and histiocytic disorders.

@en

P2093

Alexis Cruz-Chacon

http://www.w3.org/2001/XMLSchema#string

Ernesto Ayala

http://www.w3.org/2001/XMLSchema#string

John Mathews

http://www.w3.org/2001/XMLSchema#string

P2860

Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net

Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step

Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).

Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients.

Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis.

Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents.

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.

Optimal therapy for adults with Langerhans cell histiocytosis bone lesions.

Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized.

P304

335-342

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327481402100410

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25310215

http://www.w3.org/2001/XMLSchema#string

P932

5798615

http://www.w3.org/2001/XMLSchema#string